首页> 美国卫生研究院文献>Experimental Diabetes Research >Metabolic Disorders and Diabetic Complications in Spontaneously Diabetic Torii Leprfa Rat: A New Obese Type 2 Diabetic Model
【2h】

Metabolic Disorders and Diabetic Complications in Spontaneously Diabetic Torii Leprfa Rat: A New Obese Type 2 Diabetic Model

机译:自发性糖尿病患者的代谢紊乱和糖尿病并发症fa大鼠:一种新型的肥胖2型糖尿病模型

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Spontaneously Diabetic Torii Lepr fa (SDT fatty) rat, established by introducing the fa allele of the Zucker fatty rat into SDT rat genome, is a new model of obese type 2 diabetes. Both male and female SDT fatty rats show overt obesity, and hyperglycemia and hyperlipidemia are observed at a young age as compared with SDT rats. With early incidence of diabetes mellitus, diabetic complications, such as nephropathy, retinopathy, and neuropathy, in SDT fatty rats were seen at younger ages compared to those in the SDT rats. In this paper, we overview pathophysiological features in SDT fatty rats and also describe new insights regarding the hematology, blood pressure, renal complications, and sexual dysfunction. The SDT fatty rats showed an increase of leukocytes, especially the monocyte count, prominent hypertension associated with salt drinking, end-stage renal disease with aging, and hypogonadism. Unlike other diabetic models, the characteristic of SDT fatty rat is to present an incidence of diabetes in females, hypertension, and retinopathy. SDT fatty rat is a useful model for analysis of various metabolic disorders and the evaluation of drugs related to metabolic disease.
机译:通过将Zucker肥胖大鼠的fa等位基因引入SDT大鼠基因组而建立的自发性糖尿病大鼠Torii Lepr fa (SDT脂肪)大鼠是肥胖2型糖尿病的新模型。雄性和雌性SDT脂肪大鼠均表现出明显的肥胖,与SDT大鼠相比,年轻时观察到高血糖和高脂血症。与SDT大鼠相比,在SDT脂肪大鼠中,发现糖尿病的早期发病率更高,因此在SDT脂肪大鼠中发现糖尿病并发症,例如肾病,视网膜病和神经病。在本文中,我们概述了SDT脂肪大鼠的病理生理特征,并描述了有关血液学,血压,肾脏并发症和性功能障碍的新见解。 SDT肥胖大鼠表现出白细胞增加,尤其是单核细胞计数增加,与食盐有关的高血压,年龄大的终末期肾脏疾病和性腺功能减退。与其他糖尿病模型不同,SDT肥胖大鼠的特征是在女性,高血压和视网膜病变中表现出糖尿病的发病率。 SDT脂肪大鼠是用于分析各种代谢异常和评估与代谢疾病相关的药物的有用模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号